Every figure on this page comes from documents Ionis Pharmaceuticals, Inc. filed with the exchange, and each one was checked against the document itself before publication. What could not be verified is not here.
| Quarter | Revenue | YoY | Net profit | YoY | Net margin |
|---|---|---|---|---|---|
| Jun 2026 | $268 mn | -40.7% | $-115 mn | -192.8% | -42.8% |
| Mar 2026 | $246 mn | +87.0% | $-93 mn | +37.0% | -37.6% |
| Dec 2025 | $203 mn | -10.3% | $-229 mn | -119.8% | -112.8% |
| Sep 2025 | $157 mn | +17.1% | $-129 mn | +8.5% | -82.1% |
| Jun 2025 | $452 mn | +100.7% | $124 mn | +286.4% | 27.3% |
| Mar 2025 | $132 mn | +10.1% | $-147 mn | -2.9% | -111.6% |
Watch it, and each morning it files something you get the checked numbers, the sources, and red-flag alerts when the quiet numbers move — pledges, ratings, resignations. Ask by name any evening and it is read overnight.
Start free — first week on us →Data from documents filed with the exchanges, checked against the documents themselves. This page states facts and is not investment advice or a recommendation. Investment in securities markets is subject to market risks. Research on this site is produced with substantial use of AI and verified against filed documents. Terms, disclosures and grievances